Jason joined Thomas, McNerney & Partners in 2007 after spending four years as a member of the investment team at Forward Ventures, where he played an active role in Forward-led rounds of investment totaling over $50 million. Prior to joining Forward, Jason conducted research in antimicrobial drug discovery and bacterial genomics as a postdoctoral fellow in Infectious Diseases at Johnson & Johnson Pharmaceutical Research and Development. He is currently a board member of  Tioga Pharmaceuticals, Inc. Jason earned a Ph.D. in Biology at the University of California, San Diego, where he was a National Science Foundation Fellow, and a B.S. in Molecular Biology and Biochemistry from Purdue University.